enVVeno Medical (NVNO) EPS (Basic) (2017 - 2026)
enVVeno Medical's (NVNO) quarterly EPS (Basic) came in at -$6.18 in Q1 2026, up 24.14% year-on-year from -$4.98 in Q1 2025, and up 7.56% quarter-over-quarter from -$6.68 in Q4 2025.
enVVeno Medical (NVNO) EPS (Basic) (2017 - 2026) Analysis & Trends
enVVeno Medical's EPS (Basic) history runs 10 years deep, the most recent figure standing at -$6.18 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 24.14% year-over-year to -$6.18 in Q1 2026; TTM through Mar 2026 was -$29.87, a 24.59% increase from a year earlier, with the FY2025 full-year figure at -$34.98, up 28.08% from the prior year.
- EPS (Basic) advanced to -$6.18 in Q1 2026 per NVNO's latest filing, from -$6.68 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$6.18 in Q1 2026 and bottomed at -$21763.2 in Q2 2022.
- The 5-year median for EPS (Basic) is -$13.97 (2024), against an average of -$1293.7.
- Across the five-year window, EPS (Basic) tumbled 186953.9% in 2022 and surged 99.9% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$20.93 in 2022, then declined by 4.29% to -$21.82 in 2023, then surged by 35.99% to -$13.97 in 2024, then surged by 52.17% to -$6.68 in 2025, then rose by 7.56% to -$6.18 in 2026.
- Per Business Quant, the three latest NVNO EPS (Basic) figures stand at -$6.18 (Q1 2026), -$6.68 (Q4 2025), and -$8.18 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | -6.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.18 |
| Dec 31, 2025 | -6.68 |
| Sep 30, 2025 | -8.18 |
| Jun 30, 2025 | -11.79 |
| Mar 31, 2025 | -8.14 |
| Dec 31, 2024 | -13.97 |
| Sep 30, 2024 | -13.24 |
| Jun 30, 2024 | -11.72 |
| Mar 31, 2024 | -11.87 |
| Dec 31, 2023 | -21.82 |
| Sep 30, 2023 | -16.53 |
| Jun 30, 2023 | -21.24 |
| Mar 31, 2023 | -21.18 |
| Dec 31, 2022 | -20.93 |
| Sep 30, 2022 | -19.02 |
| Jun 30, 2022 | -21,763.24 |
| Mar 31, 2022 | -16.63 |
| Dec 31, 2021 | -36.24 |
| Sep 30, 2021 | -9.11 |
| Jun 30, 2021 | -11.63 |